Quick Answer
Definitive Healthcare Corp. reported R&D Expense of $34.78 million for fiscal year 2025.
Definitive Healthcare Corp. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $34.78M | -4.8% |
| 2024 | $36.52M | -14.0% |
| 2023 | $42.44M | +21.6% |
| 2022 | $34.89M | +87.9% |
| 2021 | $18.57M | +67.8% |
| 2020 | $11.06M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.55M | +3.7% | -5.2% |
| June 30, 2025 | $7.97M | -21.3% | -14.3% |
| March 31, 2025 | $9.30M | -8.2% | +27.7% |
| September 30, 2024 | $7.28M | -32.3% | -28.1% |
| June 30, 2024 | $10.12M | -1.0% | -0.1% |
| March 31, 2024 | $10.13M | +2.5% | -5.8% |
| September 30, 2023 | $10.76M | +16.9% | +5.2% |
| June 30, 2023 | $10.23M | +17.5% | +3.5% |
- Definitive Healthcare Corp. showed a decrease of -4.8% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Definitive Healthcare Corp.’s r&d expense has grown by 214.4% (from $11.06 million to $34.78 million).
- The most recent figure is from Definitive Healthcare Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: